MEMO available in 23 languages: What are the challenges of information on medicines in the EU? What does the Commission set out to achieve with these proposals? What 's new in these amended proposals? How do you distinguish between information and advertising? How would the proposals ensure that information is objective and non-promotional? Would it be possible to give information on medicines via television, radio or via other media? How about information over the internet? Would this still be allowed? What are the next steps?